Leishmaniasis carries a powerful and infamous stigma in endemic societies as the most neglected tropical diseases in the world (Center for Disease Control and Prevention (CDC), 2010b). The stigma has been obtained through years of globally debilitating the destitute in a manor of discrepancy. The opportunistic disease preys disproportionately on countries of lower-income, weak surveillance and limited access to care; consequently, Leishmaniasis never gains recognition by non-governmental organizations (NGO) or private donors as a significant threat (Boer, Argaw, Jannin & Alvar, 2011). Therefore, the disease is free to continuously plague individuals with little hope of resolution. Annually, 1.5 million individuals contract Cutaneous Leishmaniasis (CL), whereas, Visceral Leishmaniasis (VL) afflicts 500,000 (World Health Organization (WHO), 2012l). Leishmaniasis is caused by the Leishmania parasite and is transmitted by a female sandfly (CDC, 2010d). Once the protozoan enters the host, the disease multiplies and spreads; subsequently, causing CL skin lesions or inflammation of organs upon contraction of VL. VL, if untreated, is fatal (CDC, 2010c; CDC, 2010d).
|Presenter:||Sean Lefferts (Undergraduate Student)|
|Location:||Lobby of Edwards|
|Time:||1:15 pm (Session III)
Please note that presentation times are approximate. If you are interested in attending sessions with multiple presentations, please be in the room at the start of the session.